Wolverine Trading, LLC Horizon Therapeutics Public LTD CO Transaction History

Wolverine Trading, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $251,777 - $368,977	-3,171 Reduced 39.51%	4,854 $400,000
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $253,469 - $322,072	2,933 Added 57.6%	8,025 $849,000
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $160,455 - $195,213	-1,628 Reduced 24.23%	5,092 $551,000
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $298,247 - $358,150	-3,245 Reduced 32.56%	6,720 $738,000
Q2 2021 Aug 06, 2021	SELL	$86.24 - $95.92 $101,418 - $112,801	-1,176 Reduced 10.56%	9,965 $945,000
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $1.13 Million - $1.5 Million	-15,671 Reduced 58.45%	11,141 $971,000
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $470,340 - $592,417	-7,020 Reduced 20.75%	26,812 $1.94 Million
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $1.35 Million - $1.95 Million	24,431 Added 259.88%	33,832 $2.64 Million
Q2 2020 Aug 13, 2020	SELL	$30.2 - $56.98 $453 - $854	-15 Reduced 0.16%	9,401 $520,000
Q4 2019 Feb 12, 2020	SELL	$25.43 - $36.67 $343,610 - $495,485	-13,512 Reduced 58.93%	9,416 $339,000
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $102,350 - $124,466	-4,450 Reduced 16.25%	22,928 $632,000
Q2 2019 Aug 20, 2019	BUY	$22.81 - $28.48 $624,492 - $779,725	27,378 New	27,378 $659,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.